Trial | NCT00892554  Report issue

Title

The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
The Impact of Docosahexaenoic Acid on Neuropsychological Status in Females With Phenylketonuria

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    33
The purpose of this study is to determine if taking supplemental DHA improves measures of processing speed and executive function in teen and adult women with PKU.
Study Started
Jun 30
2007
Primary Completion
Jan 31
2010
Study Completion
Jan 31
2010
Last Update
Dec 11
2015
Estimate

Dietary Supplement Docosahexaenoic Acid

Capsules providing 10 mg DHA/kg body weight/day taken once daily

  • Other names: DHASCO-S

Dietary Supplement Corn/soy oil

Capsules taken once daily

DHA supplementation Experimental

corn/soy capsule, no DHA Placebo Comparator

Criteria 

Inclusion Criteria:

Females
Phenylketonuria
Ages 12 years and older
Able to complete neuropsychological testing

Exclusion Criteria:

Pregnancy
Currently taking DHA supplement
No Results Posted